Tech Company Financing Transactions
FreeStride Therapeutics Funding Round
Michigan Pre-Seed Capital Fund participated in a $100 thousand Seed funding round for FreeStride Therapeutics. The round was announced on 7/13/2012.
Transaction Overview
Company Name
Announced On
7/13/2012
Transaction Type
Venture Equity
Amount
$100,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2403 Vinewood Blvd.
Ann Arbor, MI 48104
USA
Ann Arbor, MI 48104
USA
Phone
Email Address
Not Recorded
Overview
FreeStride Therapeutics is developing therapies for treatment of bone-related conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Olson
Chief Operating Officer
Michael Long
Browse more venture capital transactions:
Prev: 7/12/2012: Copious venture capital transaction
Next: 7/13/2012: Aerial BioPharma venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs